Patents Assigned to Murray Goulburn Co-Operative Co. Limited
-
Patent number: 9839676Abstract: The invention provides a method for treating cancer in a subject or a method of inducing an anti-tumour effect including reducing tumour volume, inhibiting or slowing tumour growth, inhibiting tumour progression, altering the metabolic activity of a tumour, inducing quiescence of a tumour, inhibiting or reducing metastasis, inhibiting or reducing tumour invasiveness, reducing tumour weight, reducing tumour neovascularisation, improving time to disease progression (TDP) and/or improving survival, the method comprising administering to the subject an effective amount of angiogenin or an angiogenin agonist.Type: GrantFiled: May 10, 2013Date of Patent: December 12, 2017Assignees: Murray Goulburn Co-Operative Co., Limited, AGRICULTURE VICTORIA SERVICES PTY LTDInventors: Peter Hobman, Andrew Brown
-
Patent number: 9789168Abstract: The invention provides a method of treating a disorder characterized by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.Type: GrantFiled: July 28, 2015Date of Patent: October 17, 2017Assignees: AGRICULTURE VICTORIA SERVICES PTY LTD, Murray Goulburn Co-Operative Co., LimitedInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman, Andrew Brown, Michelle Rowney
-
Patent number: 9480717Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.Type: GrantFiled: September 4, 2012Date of Patent: November 1, 2016Assignee: Murray Goulburn Co-Operative Co LimitedInventors: Michelle Rowney, David Cameron-Smith
-
Patent number: 9247766Abstract: The invention provides methods for enriching a milk extract for angiogenin, such methods involving separation by size, charge or immunoaffinity. The invention also provides the angiogenin enriched extract produced by the methods and provides them in pharmaceutical and neutraceutical compositions and foods for treating a variety of diseases or disorders that can be treated by angiogenin.Type: GrantFiled: May 14, 2009Date of Patent: February 2, 2016Assignees: Murray Goulburn Co-Operative Co., Limited, Agriculture Victoria Services Pty Ltd.Inventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman, Andrew Brown
-
Patent number: 9119818Abstract: The invention provides a method of treating a disorder characterized by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.Type: GrantFiled: May 14, 2009Date of Patent: September 1, 2015Assignees: AGRICULTURE VICTORIA SERVICES PTY LTD, Murray Goulburn Co-Operative Co., LimitedInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman
-
Publication number: 20150173396Abstract: The invention provides methods for improving at least one physicochemical property of a product comprising casein micelles, the method comprising applying carbon dioxide to an aqueous product comprising casein micelles to reduce the pH of the product; increasing the pH of the product; and collecting the product comprising casein micelles, in which at least some of the casein micelles of the product are modified in structure by one or more of steps a) and b) compared to naturally occurring casein micelles thereby improving at least one physicochemical property of the product comprising casein micelles. The method reduces viscosity and improves mouth feel of reconstituted product, reduces rehydration time for dried product, improves cheese manufacturing by reducing rennetting or clotting time in cheese manufacture or reducing the amount of rennet required in cheese manufacture.Type: ApplicationFiled: June 20, 2013Publication date: June 25, 2015Applicant: MURRAY GOULBURN CO-OPERATIVE CO. LIMITEDInventors: Darren Gardiner, Peter Hobman
-
Patent number: 8551547Abstract: The invention provides a process for the preparation of an angiogenin-enriched fraction from a milk product, the process comprising contacting the milk product with a cation exchange resin and eluting the angiogenin-enriched fraction from the cation exchange resin with a mobile phase. The invention also provides angiogenin-enriched fractions produced by process and food products, nutraceuticals and pharmaceutical comprising such angiogenin.Type: GrantFiled: November 9, 2007Date of Patent: October 8, 2013Assignees: Murray Goulburn Co-operative Co., Limited, Agriculture Victoria Services Pty Ltd.Inventors: Andrew Brown, Michelle Rowney, Peter Hobman, Matthew McDonagh, Angus Tester, Benjamin Cocks
-
Publication number: 20130243728Abstract: The invention relates to a recombinant microorganism comprising a transgene encoding angiogenin and optionally follistatin, a food product, beverage product or animal feed produced from or comprising said microorganism and uses thereof.Type: ApplicationFiled: November 18, 2010Publication date: September 19, 2013Applicants: Agriculture Victoria Services PTY LTD, Murray Goulburn Co-Operative Co. LimitedInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Ross Crittenden
-
Publication number: 20130236508Abstract: The method relates to a method of treating proteinuria comprising administering lactoferrin.Type: ApplicationFiled: June 24, 2011Publication date: September 12, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO. LIMITEDInventors: Peter Hobman, Kerrie Sanders, Michelle Rowney, Geoff Nicholson
-
Publication number: 20130195990Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.Type: ApplicationFiled: September 4, 2012Publication date: August 1, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Michelle ROWNEY, David CAMERON-SMITH
-
Publication number: 20130078313Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as methods for supplementing the nutritional needs of individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to increase skeletal muscle strength.Type: ApplicationFiled: May 24, 2012Publication date: March 28, 2013Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Michelle ROWNEY, David CAMERON-SMITH, Scott CONNELLY
-
Publication number: 20130039889Abstract: The invention relates to a recombinant microorganism comprising a transgene encoding angiogenin and optionally follistatin, a food product, beverage product or animal feed produced from or comprising said microorganism and uses thereof.Type: ApplicationFiled: November 18, 2011Publication date: February 14, 2013Applicants: Agriculture Victoria Services PTY LTD, Murray Goulburn Co-Operative Co. LimitedInventors: Matthew McDonagh, Benjamin Cocks, Angus Tester, Ross Crittenden
-
Publication number: 20120331575Abstract: The invention provides a non-human transgenic animal comprising a transgene encoding angiogenin and food products comprising or obtained from the non-human transgenic animal and uses thereof.Type: ApplicationFiled: November 18, 2010Publication date: December 27, 2012Applicants: Agriculture Victoria Services PTY LTD, Murray Goulburn Co-Operative Co. LimitedInventors: Peter Hobman, Matthew McDonagh, Benjamin Cocks, Angus Tester
-
Patent number: 8282927Abstract: The invention relates to the production of compositions containing IgA for use as a food additive. More specifically, it relates to a process to prepare an IgA-enriched milk product extract composition and to such compositions.Type: GrantFiled: May 10, 2006Date of Patent: October 9, 2012Assignee: Murray Goulburn Co-Operative Co LimitedInventors: Andrew Brown, Peter Hobman, Richard Paine, Michelle Rowney
-
Publication number: 20110262422Abstract: The invention provides a method of treatment of any disorder in which administration of angiogenin is beneficial wherein the angiogenin is administered orally. Particularly, the oral angiogenin does not require a carrier or excipient or for the protein to be encapsulated or subjected to any other mechanism to improve its oral bioavailability.Type: ApplicationFiled: May 14, 2009Publication date: October 27, 2011Applicants: MURRAY GOULBURN CO-OPERATIVE CO., LIMITED, AGRICULTURE VICTORIA SERVICES PTY LTD.Inventors: Benjamin Cocks, Angus Tester, Peter Hobman, Matthew McDonagh
-
Publication number: 20100062124Abstract: A process for the production of a commercial mineral whey product derived from a feed stream of milk or whey, said process including the steps of: primary de-mineralisation of the feed stream, preferably carried out by either membrane separation or ion exchange to produce a high potassium stream and a demineralised stream; secondary demineralisation of the high potassium stream, either by precipitation and subsequent separation of a predominantly calcium-phosphate complex, or by the removal of calcium by ion exchange; concentrating the high potassium stream to obtain a concentrate having a total solids content of around 20 to 60% by weight; and further processing of said concentrated said high potassium stream into a desired form for storage and distribution.Type: ApplicationFiled: June 23, 2006Publication date: March 11, 2010Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventor: Michael John Phillips
-
Publication number: 20090214567Abstract: The invention relates to the production of compositions containing IgA for use as a food additive. More specifically, it relates to a process to prepare an IgA-enriched milk product extract composition and to such compositions.Type: ApplicationFiled: May 10, 2006Publication date: August 27, 2009Applicant: MURRAY GOULBURN CO-OPERATIVE CO LIMITEDInventors: Andrew Brown, Peter Hobman, Richard Paine, Michelle Rowney
-
Patent number: 5783237Abstract: A process is provided for the recovery and reuse of a salt solution obtained from a salty effluent (as herein defined) comprising: (1) passing said salty effluent, optionally after removing any fine particles therefrom, through a membrane filtration system which separates the salt in the form of a salt solution from the food residues; (2) passing said salt solution through an evaporator to decrease the water content thereof; (3) adjusting the temperature of the salt solution, typically within the range 15.degree.-25.degree. C.Type: GrantFiled: April 15, 1996Date of Patent: July 21, 1998Assignee: Murray Goulburn Co-Operative Co. LimitedInventors: Wayne Barry Sanderson, Anthony Phillip Brady, Graeme Frank Whitehead, Ian James Oldham, Ian Percival Brockwell